Paul Edwards

Paul Edwards MBE

IsomAb

---

Paul has over 40 years’ experience in the pharmaceutical and life science arena. He initially
worked for Beecham Pharmaceuticals before joining Genzyme Corporation, where he headed
the UK operations for the company. In 2000, he joined the UK based biosimilars’ organisation,
GeneMedix plc as Chief Executive Officer, and successfully led a major funding round taking the
company to a dual listing on the London and Singapore Stock Exchanges. More recently, Paul
has acted as a NED to Goldshield Group plc and BioProducts Laboratories and oversaw the sale
of both organisations to Private Equity Groups. He acted as interim CEO to NanoMab
Technology Ltd as well as serving as Managing Partner and board member of the global
Executive Search Group, SCi Partners.

Paul is a familiar face in the UK biotech arena and is currently the Chair of OBN (UK) Ltd,
representing over 400 members companies in the UK Life Science sector. He has recently
become the Executive Chair of IsomAb Ltd, a spin-out company from the University of
Nottingham as well as a SAB member for Imophoron Ltd.
In 1997 he received an MBE for services to biotechnology